Held for Sale and Discontinued Operations Held for Sale and Discontinued Operations

6 Months Ended

Jun. 30, 2020

Held for Sale and Discontinued Operations [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

Discontinued operations previously held for sale

DaVita Medical Group

On June 19, 2019, the Company completed the sale of its DaVita Medical Group (DMG) business to Optum, a subsidiary of UnitedHealth Group Inc., for an aggregate purchase price of $4,340,000, prior to certain closing and post-closing adjustments specified in the related equity purchase agreement dated as of December 5, 2017, as amended as of September 20, 2018 and as of December 11, 2018 (as amended, the equity purchase agreement).

The Company recorded a preliminary estimated pre-tax net loss of approximately $23,022 on the sale of its DMG business in 2019. This preliminary net loss was based on initial estimates of the Company's expected aggregate proceeds from the sale, net of transaction costs and obligations, as well as the estimated values of DMG net assets sold as of the closing date. These estimated net proceeds included $4,465,476 in cash received from Optum at closing, or $3,824,509 net of cash and

restricted cash included in the DMG net assets sold. During the six months ended June 30, 2020, the Company recognized $9,980 in additional tax benefits under the Coronavirus Aid, Relief, and Economic Security Act related to its period of DMG ownership, which have been recognized as an adjustment to the Company's loss on sale of the DMG business.

The ultimate net proceeds from the DMG sale, as well as the value of its previously held for sale net assets sold, remain subject to estimate revisions and post-closing adjustments pursuant to the equity purchase agreement, which could be material. The Company continues to work with Optum concerning what, if any, net working capital adjustment or other potential adjustments to the purchase price are appropriate, via the process set forth in the equity purchase agreement. Under the equity purchase agreement, the Company also has certain indemnification obligations that could require payments to the buyer relating to the Company's previous ownership and operation of the DMG business. Potential payments under these provisions, if any, remain subject to significant uncertainties and could have a material adverse effect on the net proceeds ultimately retained by the Company or the total amount of its loss on the sale of this business.

The following table presents the financial results of discontinued operations related to DMG:



	Three months ended June 30,					Six months ended June 30,
	2020		2019			2020		2019
Revenues	$	—	$	1,330,777		$	—	$	2,713,059
Expenses	—		1,201,633			—		2,539,787
Income from discontinued operations before taxes	—		129,144			—		173,272
(Loss) gain on sale of discontinued operations before taxes	—		(23,022		)	9,980		(23,022		)
Income tax expense	—		26,730			—		40,553
Net income from discontinued operations, net of tax	$	—	$	79,392		$	9,980	$	109,697

The following table presents cash flows of discontinued operations related to DMG:



	Six months ended June 30,
	2020		2019
Net cash provided by operating activities from discontinued operations	$	—	$	103,848
Net cash used in investing activities from discontinued operations	$	—	$	(43,442	)